CG Oncology, Inc. (CGON) income statement
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$79.47−2.43 (-2.97%)
Close on Nov 20, 2026Market cap $7.04BP/E –Yield –
CG Oncology, Inc. financial ratios
See a number that looks wrong?